{
  "pmcid": "11364141",
  "sha256": "c2c0c29231dbf0eef2fe95d072699bf3f9e0bfdd0edc28f053b87904aa348ce3",
  "timestamp_utc": "2025-11-09T15:18:23.074003+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 12.380650406504063,
    "reading_ease": 30.64138211382115,
    "word_count": 246
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "A sample size of 30 patients was calculated to test postoperative complication rates against predefined cut-offs."
      },
      "Participants": {
        "score": 2,
        "evidence": "patients with sporadic, resectable or potentially resectable NF-PanNETs at high-risk of recurrence; those with positive 68 Ga-labelled DOTA PET were eligible."
      },
      "Intervention": {
        "score": 2,
        "evidence": "All patients were candidates for neoadjuvant 177 Lu-DOTATATE followed by surgery."
      },
      "Objective": {
        "score": 1,
        "evidence": "The primary aim of this study was to evaluate the safety of neoadjuvant 177 Lu-labelled DOTA 0 -octreotate ( 177 Lu-DOTATATE) followed by surgery in patients with NF-PanNETs."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary endpoint was safety, reflected by postoperative morbidity and mortality within 90 days."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "From March 2020 to February 2023, 31 patients were enrolled"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "26 completed 4 cycles of 177 Lu-DOTATATE."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "A partial radiological response was observed in 18 of 31 patients, and 13 patients had stable disease."
      },
      "Harms": {
        "score": 1,
        "evidence": "Postoperative complications occurred in 21 of 29 patients. Severe complications were observed in seven patients."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 15,
    "max_score": 25
  }
}